Collagen is the major structural component of skin, hair, nails, joints and bones. In order to localize collagen production, Dermal Collagen Peptides use leading bioactive peptides, clinically proven to target collagen production and counter collagen decline – directly at dermal tissue.

Dermal Collagen Peptides consist of Type I and Type III bovine peptides known as Verisol®. These peptides specifically signal and simulate fibroblast cells to synthesize collagen production in the skin and nails. Their amino acid profile is predominantly made up of small peptides in the range of 4-5 amino acids (2kDa or Kilodaltons) or less. This is important because small peptides allow for absorption of the entire peptide chain without being broken down during digestion.

Multiple, double-blind, randomized placebo controlled trials have been published on these bioactive peptides and proven their effectiveness for skin health. Research has found that supplementing for 4 weeks with these bioactive peptides can increase skin elasticity by up to 15% and increase collagen content by 60%.

Incredibly, a reduction in the visibility of fine wrinkles has also been noted after only 4 weeks, with reductions in cellulite content of the skin after 3 months. Unlike most cellulite products on the market which focus on fat reduction or improving circulation, these bioactive and small peptides uniquely stimulate the formation of extracellular matrices within the skin.

When it comes to nail health, research has shown less chipping and faster nail growth after 2 months and 3 months, respectively, of supplementation with these bioactive peptides.

Dermal Collagen Peptides contain 300 grams of bioactive peptides per container. This allows for a total of 120 servings at the evidence-based dosage of 2.5g per day.